Filter events

  • International News | 30.01.2014

    Designation of a WHO Collaborating Centre for the Surveillance of Anti-malarial Drug Ressistance - Institut Pasteur in French-Guiana

    The World Health Organisation has designed the Laboratoire de Parasitologie de l'Institut Pasteur de la Guyane as WHO Collaborating Centre for the Surveillance of Anti-malarial Drug Resistance.

    Lise Musset and Eric Legrand will act as Heads of this new Centre attached to the WHO Americas Region (AMRO). This designation as a WHO Collaborating Centre (WHOCC) is effective for a period of four years from January 2014 to January 2018.

    The Institut Pasteur in French Guiana, headed by Dr Philippe Quenel, carries out activities of 4 National Reference Centres (NRC) - laboratories associated to the West Indies and Guiana region, appointed by decree of the Ministry of Health for a term of 5 years from 2012 to 2016:
    • 3 CNR in the Virology Laboratory: respectively Arbovirus, Influenzae viruses and Hantavirus
    • 1 CNR in the Laboratory of Parasitology for malaria surveillance

    This new WHO Collaborating Centre increase to 19 the number of WHOCC in the Institut Pasteur International Network including 8 WHOCC at the Institut Pasteur in Paris.

    Malaria is a disease that can be fateful. It is caused by parasites transmitted to humans through the bites of infected mosquitoes. In 2012, malaria was responsible for 627,000 deaths mostly among African children under 5 years. In French Guiana, malaria affects each year between 2 000 and 5 000 patients it is endemic on the rivers borders with Suriname (Maroni), with Brazil (Oyapock) and within the Saul's region. Plasmodium falciparum and Plasmodium vivax are the most common parasites, however, P. falciparum is the most lethal.

  • International News | 24.01.2014

    Alejandro Buschiazzo from the Institut Pasteur in Montevideo is the laureat of the 2014 François Jacob’s Prize

    Alejandro Buschiazzo awarded the François Jacob’s Prize given by Professor Christian Bréchot, President of the Institut Pasteur on January 24th, 2014. This Award recognizes his work on crystallography, his great commitment in the interface with the Institut Pasteur International Network especially in a leptospirosis' project and the creation of a structural biology network in Latin America.

    The François Jacob Prize, created following the will of François Jacob after a Pasteur Foundation’s donation in United States, awardded this year this researcher at the Institut Pasteur in Montevideo, member of the Institut Pasteur International Network.

    Alejandro Buschiazzo heads the Proteins Crystallography Unit in Montevideo since 2006, after a PhD at the Buenos Aires University, a postdoctoral traineeship in the Pedro Alzari’s Unit and finally a young researcher position in the same unit within the Institut Pasteur in Paris. The scientific work of his team is dedicated to the interface between Biology, Biochemistry and Molecular Biology by focusing on the structural study of proteins-proteins and protein-DNA complexes involved in several pathologies such as leptospirosis and trypanosomiasis.


  • International News | 20.01.2014

    Signing of an agreement with Myanmar within the framework of the ECOMORE project

    The Institut Pasteur, the Institut Pasteur in Cambodia, the National Health Laboratory (based in Yangon), and the national Health authorities of the Republic of the Union of Myanmar signed a first Technical Collaborative Agreement within the framework of the ECOMORE project (“ECOnomic Development, ECOsystem MOdifications, & Emerging Infectious Diseases Risk Evaluation”). This ambitious project, supported by the AFD, aims in Myanmar to strengthen the national capacities for diagnostic and surveillance of severe respiratory infectious diseases, mainly affecting children.

    The signature of this agreement was held on January 20th, 2014 in Yangon in the presence of His Excellency the Ambassador of France in Myanmar, the General Secretary of the Institut Pasteur International Network, the representative of AFD, the Director of the National Health Laboratory, the Director of the Institut Pasteur in Cambodia, and their respective teams involved in the project. 

    This ceremony was also the opportunity to organize a first meeting of detailed information on the project to be implemented in Myanmar with all the national stakeholders as well as a global presentation of the other topics to be dealt within the project by the other participating countries.

  • Research | 17.01.2014

    A new bacterial mechanism for evading the immune system

    A team of scientists from the Institut Pasteur, the CNRS and Paris Diderot University has identified a new regulation mechanism that enables a pathogenic bacterium of the Streptococcus genus to rapidly adapt to its host. This study was published on January 16, 2014 in PLoS Pathogens. The mechanism in question enables the bacterium to minimize its exposure to the immune system while maintaining effective tissue colonization. This work was carried out on Streptococcus gallolyticus, an intestinal tract bacterium responsible for endocarditis and septicemia in the elderly.

  • International News | 13.01.2014

    Professor Patrick Berche new President ot the Institut Pasteur in Lille

    Pr Patrick Berche will take over as President of the Institut Pasteur in Lille in July 1st, 2014 after formal appointment on January 10th, 2014.

    Patrick Berche holds the position of Dean of the Faculty of Medicine Paris-Descartes, his mandate will end on June 30th, 2014. He will be in charge of the Institut Pasteur’s Scientific Director in Lille from January to June 2014.

    Medical doctor and expert researcher in microbiology, Patrick Berche has been a member of the INSERM‘s scientific committee specialized on the infectious diseases. He chaired the Committee of the National Reference Centers of Institute for Public Health Surveillance (InVs) from 2006 to 2011.

    Patrick Berche has made many humanitarian missions and in particular he established and piloted from 1992 to 2000 the project against infantile diarrhea and cholera in South America.

  • Research | 19.12.2013

    Molecular marker discovered for detecting artemisinin-resistant forms of malaria

    Scientists at the Institut Pasteur in Paris and Cambodia, CNRS and NIH have identified a molecular marker for detecting malaria parasites with resistance to artemisinin derivatives

    Un marqueur moléculaire permettant de détecter les parasites du paludisme résistants aux dérivés de l’artémisinine, constituants majeurs des traitements antipaludiques actuellement recommandés par l’OMS, a été identifié par des scientifiques de l’Institut Pasteur à Paris, de l’Institut Pasteur du Cambodge, du CNRS et des National Institutes of Health (NIAID/NIH).

  • Research | 13.12.2013

    A prime target for the development of anti-inflammatories

    For the first time, scientists from the Institut Pasteur and Inserm have demonstrated the key role played by a particular molecule in intestinal infection.

  • Research | 12.12.2013

    Carriers of a genetic mutation show increased dependence on tobacco

    Scientists at the Institut Pasteur, the French National Center for Scientific Research (CNRS) and Pierre and Marie Curie University (UPMC) have recently proven that, in mice, nicotine intake – nicotine is the main addictive substance in tobacco – is heavily regulated by a genetic mutation that is very common in humans. 

  • Research | 28.11.2013

    Clinical trial launched to treat Sanfilippo B syndrome using gene therapy

    A phase I/II gene therapy clinical trial for children suffering from Sanfilippo B syndrome, a rare genetic disease, enrolled a first patient in October of this year. The trial is being carried out and coordinated by the Institut Pasteur (the trial’s sponsor), Inserm, AFM-Téléthon and Vaincre les Maladies Lysosomales (VML). It is being conducted at Bicêtre Hospital (AP-HP) in Paris. If the treatment is successful it will pave the way towards the development of other gene therapy treatments using the same process.

  • Research | 05.11.2013

    Two European programs reinforce the fight against emerging diseases

    The 31 partners involved in the two major European research programs PREDEMICS and ANTIGONE are to meet for a joint seminar at the Institut Pasteur on November 6th. These two programs will respectively receive €11.7 million and €12 million funding of the European Union over five years to study the emergence mechanisms of infectious diseases in order to strengthen existing treatment and prevention. Since their launch, PREDEMICS and ANTIGONE have been active in various areas, in particular for modeling the spread and evolution of emerging pathogens and for studying host-pathogen interactions.


Pasteur museum

Welcome to Pasteur Museum


The Pasteur Museum is located at the Institut Pasteur, situated at: 25 rue du Docteur Roux 75015 Paris, France

Pasteur Museum